Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Anxiety: Overview01:18

Anxiety: Overview

332
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
332
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

178
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
178
Social Anxiety Disorder01:28

Social Anxiety Disorder

70
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
70
Panic Disorder01:27

Panic Disorder

163
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
163
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

423
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
423
Obsessive-Compulsive Disorder01:28

Obsessive-Compulsive Disorder

180
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
180

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
Same author

Predictors of response to biofeedback-assisted relaxation for migraine: An exploratory analysis.

Cephalalgia : an international journal of headache·2026
Same author

Effects of MBSR and escitalopram on self-compassion in anxiety disorders.

Journal of psychiatric research·2026
Same author

Integrating physical activity promotion into psychological practice: Clinical and ethical considerations.

Psychology of sport and exercise·2026
Same author

When Childhood Control Slips Away: How Parental Affection and Abuse Shape Adult Anxiety and Depression.

Clinical psychology & psychotherapy·2026
Same author

Therapeutic Relationship in Group Cognitive Behavior Therapy, Yoga, and Stress Education for Generalized Anxiety Disorder.

Journal of psychotherapy integration·2025

関連する実験動画

Updated: Aug 16, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.4K

不安 障害: 概要

Kristin L Szuhany1, Naomi M Simon1

  • 1Department of Psychiatry, New York University Grossman School of Medicine, New York.

JAMA
|December 27, 2022
PubMed
まとめ

不安障害は米国の成人の34%に影響し,苦痛と障害を引き起こす. 効果的な第一線治療には,認知行動療法,サートラリンなどのSSRI,ヴェンラファクシンなどのSNRIsが含まれます.

科学分野:

  • 精神科 と 精神 保健
  • 主要治療薬

背景:

  • アメリカでは,不安障害の有意な生涯流行率は約34%です.
  • これらの疾患はしばしば慢性であり,生活の質と日常の機能に重大な障害をもたらします.
  • 一般的な不安障害には,一般的不安障害,社会的不安障害,パニック障害が含まれる.

研究 の 目的:

  • 不安障害の概要,その有病率,症状,診断方法について説明する.
  • 一般的な不安障害に対する 証拠に基づいた第一線治療法を強調します
  • 不安患者の治療法を選択する際の考慮すべき要因について臨床医に知らせる.

主な方法:

  • 米国における不安障害の流行データに関するレビュー
  • 不安障害の特徴的な症状と身体的表れについて
  • 薬物療法 (SSRI,SNRIs) と心理療法 (CBT) の有効性に関するメタアナリシスの結果の要約.

主要な成果:

  • 選択的セロトニン再吸収阻害剤 (SSRI) とセロトニン・ノルアピネフリン再吸収阻害剤 (SNRIs) は,一般的不安障害,社会的不安障害,パニック障害に対してプラセボと比較して,小から中程度の効果を示しています.
  • 認知行動療法 (CBT) は,一般的不安障害,社会的不安障害,パニック障害の効果が大きいから中等であることを示しています.

さらに関連する動画

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
11:18

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat

Published on: September 12, 2014

15.3K
Reducing State Anxiety Using Working Memory Maintenance
08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

7.6K

関連する実験動画

Last Updated: Aug 16, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.4K
Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
11:18

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat

Published on: September 12, 2014

15.3K
Reducing State Anxiety Using Working Memory Maintenance
08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

7.6K
  • 一般的な不安障害-7 (GAD-7) のような短いスクリーニングツールは,プライマリケアにおける不安障害の診断に役立ちます.

    • 結論:

    • 不安障害は蔓延し 弱体化しており 効果的な管理戦略が必要である.
    • 認知行動療法,SSRI (例えば,セルトラリン),SNRI (例えば,ヴェンラファキシン延長放出剤) が第一線治療として確立されています.
    • 治療の選択は,患者の好み,併発症,費用や治療へのアクセスなどの実用的な要因を考慮して個別化されるべきです.